Rebif and Valproic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rebif (interferon beta-1a) and Valproic acid (valproic acid). Common drug interactions include pyuria among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Rebif and Valproic acid. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Rebif?

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. eHealthMe is studying from 61,126 Rebif users. Check the latest studies of Rebif.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

23 people who take Rebif and Valproic acid together, and have interactions are studied.

Rebif and Valproic acid drug interactions.

What are the common drug interactions of Rebif and Valproic Acid, by gender? *:

female:

  1. Pyuria (a condition of urine containing pus)
  2. Restlessness (not able to rest)
  3. Sedation
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Stress symptoms
  6. Tooth fracture
  7. Tooth infection
  8. Troponin increased
  9. Urinary tract infection
  10. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)

male:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  4. Hepatotoxicity (chemical-driven liver damage)
  5. Influenza like illness
  6. Joint swelling
  7. Jugular vein thrombosis (clot in jugular vein)
  8. Loss of consciousness
  9. Pain in extremity
  10. Progressive multiple sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord)

What are the common drug interactions of Rebif and Valproic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Loss of consciousness
  7. Renal failure (kidney dysfunction)

20-29:

  1. Dizziness
  2. Headache (pain in head)
  3. Loss of consciousness
  4. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)

30-39:

  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Weight decreased
  3. Gait disturbance
  4. Influenza like illness
  5. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  6. Adenomyosis (presence of ectopic glandular tissue found in muscle)
  7. Anaemia (lack of blood)
  8. Anxiety
  9. Arrhythmia (irregular heartbeat)
  10. Blood pressure increased

40-49:

  1. Chills (felling of cold)
  2. Cough
  3. Feeling cold
  4. Headache (pain in head)
  5. Lower respiratory tract infection
  6. Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

  1. Asthenia (weakness)
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Alopecia (absence of hair from areas of the body)
  4. Apathy
  5. Aspartate aminotransferase increased
  6. Back pain
  7. Dizziness
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Gastric disorder (disease of stomach)

60+:

n/a

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 34.78%
  2. Depression: 4 people, 17.39%
  3. Cardiac Disorder: 4 people, 17.39%
  4. Sleep Disorder: 2 people, 8.70%
  5. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 8.70%
  6. Gait Disturbance: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Rebif and Valproic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rebif and Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rebif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rebif and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on interferon beta-1a and valproic acid (the active ingredients of Rebif and Valproic acid, respectively), and Rebif and Valproic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: